161 related articles for article (PubMed ID: 35881275)
1. Hypercoagulability in Cushing's syndrome: incidence, pathogenesis and need for thromboprophylaxis protocols.
Feelders RA; Nieman LK
Pituitary; 2022 Oct; 25(5):746-749. PubMed ID: 35881275
[TBL] [Abstract][Full Text] [Related]
2. The thrombotic risk in Cushing's syndrome-questions, answers, and the algorithm to consider in its assessment: part I-thrombotic risk not related to surgery.
Bryk-Wiązania AH; Minasyan M; Świątkowska-Stodulska R; Undas A; Hubalewska-Dydejczyk A; Webb SM; Valassi E; Gilis-Januszewska A
Front Endocrinol (Lausanne); 2024; 15():1350010. PubMed ID: 38529392
[TBL] [Abstract][Full Text] [Related]
3. Hypercoagulability in Cushing's syndrome: prevalence, pathogenesis and treatment.
van der Pas R; Leebeek FW; Hofland LJ; de Herder WW; Feelders RA
Clin Endocrinol (Oxf); 2013 Apr; 78(4):481-8. PubMed ID: 23134530
[TBL] [Abstract][Full Text] [Related]
4. Changes in coagulation indexes and occurrence of venous thromboembolism in patients with Cushing's syndrome: results from a prospective study before and after surgery.
Manetti L; Bogazzi F; Giovannetti C; Raffaelli V; Genovesi M; Pellegrini G; Ruocco L; Iannelli A; Martino E
Eur J Endocrinol; 2010 Nov; 163(5):783-91. PubMed ID: 20696792
[TBL] [Abstract][Full Text] [Related]
5. Current clinical practice for thromboprophylaxis management in patients with Cushing's syndrome across reference centers of the European Reference Network on Rare Endocrine Conditions (Endo-ERN).
van Haalen FM; Kaya M; Pelsma ICM; Dekkers OM; Biermasz NR; Cannegieter SC; Huisman MV; van Vlijmen BJM; Feelders RA; Klok FA; Pereira AM;
Orphanet J Rare Dis; 2022 May; 17(1):178. PubMed ID: 35505430
[TBL] [Abstract][Full Text] [Related]
6. Hypercoagulable state in Cushing's syndrome: a systematic review.
Van Zaane B; Nur E; Squizzato A; Dekkers OM; Twickler MT; Fliers E; Gerdes VE; Büller HR; Brandjes DP
J Clin Endocrinol Metab; 2009 Aug; 94(8):2743-50. PubMed ID: 19454584
[TBL] [Abstract][Full Text] [Related]
7. A venous thromboembolism risk assessment model for patients with Cushing's syndrome.
Zilio M; Mazzai L; Sartori MT; Barbot M; Ceccato F; Daidone V; Casonato A; Saggiorato G; Noventa F; Trementino L; Prandoni P; Boscaro M; Arnaldi G; Scaroni C
Endocrine; 2016 May; 52(2):322-32. PubMed ID: 26113424
[TBL] [Abstract][Full Text] [Related]
8. Incidence of venous thromboembolism in patients with Cushing's syndrome: a multicenter cohort study.
Stuijver DJ; van Zaane B; Feelders RA; Debeij J; Cannegieter SC; Hermus AR; van den Berg G; Pereira AM; de Herder WW; Wagenmakers MA; Kerstens MN; Zelissen PM; Fliers E; Schaper N; Drent ML; Dekkers OM; Gerdes VE
J Clin Endocrinol Metab; 2011 Nov; 96(11):3525-32. PubMed ID: 21880802
[TBL] [Abstract][Full Text] [Related]
9. High prevalence of venous thrombotic events in Cushing's syndrome: data from ERCUSYN and details in relation to surgery.
Isand K; Feelders R; Brue T; Toth M; Deutschbein T; Reincke M; Kršek M; Santos A; Demtröder F; Chabre O; Strasburger CJ; Aulinas Maso A; Volke V; Pereira AM; Lohmann R; Gich Saladich I; ; Webb SM; Wass J; Valassi E
Eur J Endocrinol; 2024 Jan; 190(1):75-85. PubMed ID: 38146835
[TBL] [Abstract][Full Text] [Related]
10. Hypercoagulability in Cushing's syndrome: From arterial to venous disease.
St-Jean M; Lim DST; Langlois F
Best Pract Res Clin Endocrinol Metab; 2021 Mar; 35(2):101496. PubMed ID: 33795197
[TBL] [Abstract][Full Text] [Related]
11. Adverse effects of glucocorticoids: coagulopathy.
Coelho MC; Santos CV; Vieira Neto L; Gadelha MR
Eur J Endocrinol; 2015 Oct; 173(4):M11-21. PubMed ID: 25971647
[TBL] [Abstract][Full Text] [Related]
12. Evaluation of procoagulant imbalance in Cushing's syndrome after short- and long-term remission of disease.
Ferrante E; Serban AL; Clerici M; Indirli R; Scalambrino E; Carosi G; Padovan L; Locatelli M; Arosio M; Peyvandi F; Mantovani G; Tripodi A
J Endocrinol Invest; 2022 Jan; 45(1):9-16. PubMed ID: 34115342
[TBL] [Abstract][Full Text] [Related]
13. Venous thromboembolism in patients with Cushing's syndrome: need of a careful investigation of the prothrombotic risk profile.
Koutroumpi S; Daidone V; Sartori MT; Cattini MG; Albiger NM; Occhi G; Ferasin S; Frigo A; Mantero F; Casonato A; Scaroni C
Pituitary; 2013 Jun; 16(2):175-81. PubMed ID: 22585010
[TBL] [Abstract][Full Text] [Related]
14. Hypercoagulability and Risk of Venous Thromboembolic Events in Endogenous Cushing's Syndrome: A Systematic Meta-Analysis.
Wagner J; Langlois F; Lim DST; McCartney S; Fleseriu M
Front Endocrinol (Lausanne); 2018; 9():805. PubMed ID: 30745894
[No Abstract] [Full Text] [Related]
15. Thromboembolic disease in hypercortisolism.
Capatina C; Fleseriu M
Curr Opin Endocrinol Diabetes Obes; 2021 Jun; 28(3):330-336. PubMed ID: 33741780
[TBL] [Abstract][Full Text] [Related]
16. Hypercoagulability and other risk factors in trauma intensive care unit patients with venous thromboembolism.
Van Haren RM; Valle EJ; Thorson CM; Jouria JM; Busko AM; Guarch GA; Namias N; Livingstone AS; Proctor KG
J Trauma Acute Care Surg; 2014 Feb; 76(2):443-9. PubMed ID: 24398771
[TBL] [Abstract][Full Text] [Related]
17. Patients With MEN1 Are at an Increased Risk for Venous Thromboembolism.
Lee ME; Ortega-Sustache YM; Agarwal SK; Tepede A; Welch J; Mandl A; Bansal R; Tirosh A; Piaggi P; Cochran C; Simonds WF; Weinstein LS; Blau JE
J Clin Endocrinol Metab; 2021 Jan; 106(2):e460-e468. PubMed ID: 32756962
[TBL] [Abstract][Full Text] [Related]
18. Hypercoagulability in Cushing's syndrome: the role of specific haemostatic and fibrinolytic markers.
Kastelan D; Dusek T; Kraljevic I; Polasek O; Giljevic Z; Solak M; Salek SZ; Jelcic J; Aganovic I; Korsic M
Endocrine; 2009 Aug; 36(1):70-4. PubMed ID: 19381886
[TBL] [Abstract][Full Text] [Related]
19. Venous thromboembolism in Cushing syndrome: results from an EuRRECa and Endo-ERN survey.
Cherenko M; Appelman-Dijkstra NM; Priego Zurita AL; Biermasz NR; Dekkers OM; Klok FA; Reisch N; Aulinas A; Biagetti B; Cannavo S; Canu L; Detomas M; Devuyst F; Falhammar H; Feelders RA; Ferrau F; Gatto F; Grasselli C; van Houten P; Hoybye C; Isidori AM; Kyrilli A; Loli P; Maiter D; Nowak E; Pivonello R; Ragnarsson O; Steenaard RV; Unger N; van de Ven A; Webb SM; Yeste D; Ahmed SF; Pereira AM
Endocr Connect; 2024 Jun; 13(6):. PubMed ID: 38614126
[TBL] [Abstract][Full Text] [Related]
20. Anticoagulant prophylaxis markedly reduces thromboembolic complications in Cushing's syndrome.
Boscaro M; Sonino N; Scarda A; Barzon L; Fallo F; Sartori MT; Patrassi GM; Girolami A
J Clin Endocrinol Metab; 2002 Aug; 87(8):3662-6. PubMed ID: 12161492
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
